Drug Profile
SAR 438151
Alternative Names: SAR438151Latest Information Update: 11 May 2016
Price :
$50
*
At a glance
- Originator Sanofi
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 30 Apr 2016 Discontinued - Phase-I for Undefined indication in France (unspecified route)
- 01 Aug 2013 Phase-I clinical trials in Undefined indication in France (unspecified route)